HOME >> BIOLOGY >> NEWS
Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model

SEATTLE, June 2 Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers. These findings are being presented at the 10th annual meeting of the American Society of Gene Therapy, which is convening May 30 to June 3 at the Washington State Convention & Trade Center, Seattle.

ED is the repeated inability to achieve or maintain an erection necessary for sexual intercourse. Because of the variability of symptoms, estimates of the incidence of ED vary but range from 15 million to 30 million affected men in the United States. ED is frequently associated with damage to the cavernous nerve that results from surgery for prostate cancer. Even if a patient receives a nerve-sparing procedure during surgery, recovery from ED after radical prostatectomy may take a long time.

In this study, which was led by Joseph C. Glorioso, III, Ph.D., chair of the department of biochemistry and molecular genetics, and Joel Nelson, M.D., chair of the department of urology, University of Pittsburgh School of Medicine, researchers inserted either the gene for the glial cell line derived neurotrophic factor (GDNF) or the GDNF family ligand (neurturin) into a genetically engineered herpes simplex virus (HSV). They then injected either of the recombinant viruses into the damaged cavernous nerve of rats. GDNF is an important nerve growth promoter and has been shown in other studies to contribute to survival and regeneration of penile nerves. Neurturin also is a nerve growth factor closely related to GDNF. Control mice received only the virus without the GDNF or neurterin genes inserted.

Four weeks after the treatment, rats administered HSV-GDNF exhibited significant recovery of intracavernous pressure (ICP) and systemic arterial pressure (AP) compared w
'"/>

Contact: Jim Swyers
SwyersJP@upmc.edu
412-657-4957
University of Pittsburgh Schools of the Health Sciences
2-Jun-2007


Page: 1 2

Related biology news :

1. Testosterone replacement therapy: How safe for aging men?
2. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 09, 2019 , ... Dr. Beanlands is the Vered ... Ottawa, Ontario, Canada. He is also Director of its National Cardiac PET Centre, ... the Department of Radiology, and in the Department of Cellular and Molecular medicine. , ...
(Date:1/10/2019)... ... January 10, 2019 , ... A major goal ... in vitro studies and significantly more expensive in vivo studies in order to ... To address this need, researchers have begun to adopt 3D cell culture models ...
(Date:1/8/2019)... ... January 07, 2019 , ... PureWay, a healthcare-focused provider ... Thomas Kennedy as head of sales and business development efforts, effective immediately. Mr. ... has previously worked for Johnson & Johnson Medical, Globus Medical, WRP Asia Pacific, ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... POWAY, Calif. (PRWEB) , ... January 22, 2019 , ... ... been using the Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly ... perform VetStem Regenerative Cell Therapy since 2007 and began using V-PET™ 2016. ...
(Date:1/20/2019)... ... ... On January 15 of this year, the Parents’ Guide to Cord Blood website ... M.D., Ph.D. The PGCB was founded by former physicist Dr. Frances Verter, who ... 21st year of operation, the PGCB continues its mission to educate parents with accurate ...
(Date:1/20/2019)... (PRWEB) , ... January 17, 2019 , ... ... and orchestration system software developer, and The Quick Life Science Group (Quick Healthcare ... platform. , The platform enables the global cell and gene therapy industry to ...
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 years ... 22, 2019 at 2:30pm EST will explore some of the key lessons that have ... one vendor vs. using multiple vendors, and find out how to ensure that you ...
Breaking Biology Technology:
Cached News: